Celyad Oncology SA (EBR:CYAD)
0.1750
+0.0250 (16.67%)
Nov 18, 2026, 5:35 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €7.83 million as of November 18, 2026. It is the 42,908th most valuable company in the world and the 103rd biggest in Belgium. Its market cap has decreased by 12.50% in one year.
Market Cap
7.83M
Enterprise Value
7.71M
Revenue
7.00K
Global Rank
Country Rank
#103 Belgium
PE Ratio
2.54
ChartMarket Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 7.83M, a decrease of -92.32%. That is a compound annual growth rate of -17.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 7.83M | 2.94% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 54.68B |
| argenx SE | 53.78B |
| Financière de Tubize | 10.48B |
| Hyloris Pharmaceuticals | 119.00M |
| Onward Medical | 109.16M |
| European Medical Solutions | 14.47M |
| BioSenic | 1.31M |
| Oxurion NV | 112.59K |